Li Siqi, Wang Hongrong, Wang Guanyun, Lu Xia, Yang Jigang
From the Department of Nuclear Medicine, Beijing Friendship Hospital of Capital Medical University, Beijing, China.
Department of Nuclear Medicine, Beijing Boren Hospital, Beijing, China.
Clin Nucl Med. 2023 May 1;48(5):445-447. doi: 10.1097/RLU.0000000000004584. Epub 2023 Jan 31.
18 F-FDG PET/CT was performed to evaluate possible recurrent B-cell lymphoblastic lymphoma in a 34-year-old man. The images showed multiple foci of increased activity in the nerve root and peripheral nerve. A biopsy confirmed the diagnosis of neurolymphomatosis. After receiving chemotherapy, PET/CT showed progressive disease. The patient subsequently received the CD-19 chimeric antigen receptor T-cell therapy. A follow-up PET/CT acquired 30 days after chimeric antigen receptor T-cell therapy revealed no abnormal FDG activity.
